Viral Hepatitis is a group of infectious diseases that affect the liver and can lead to severe health complications if left untreated. It is caused by different viruses, including hepatitis A, B, C, D, and E. Each type varies in transmission routes and severity of symptoms. Hepatitis A is typically contracted through contaminated food or water, while hepatitis B and C spread through contact with infected blood or body fluids such as during unprotected sex or sharing needles. Hepatitis D occurs only in individuals already infected with hepatitis B, whereas hepatitis E is usually transmitted through consuming contaminated water or undercooked meat. Symptoms may range from mild fatigue to jaundice (yellowing of the skin and eyes), dark urine, abdominal pain, nausea/vomiting, and loss of appetite. Although some people might remain asymptomatic for years after infection with viral hepatitis types B and C known as chronic infections - it can eventually cause cirrhosis (scarring) of the liver leading to organ failure or hepatocellular carcinoma (liver cancer). Early diagnosis through blood tests allows for treatments aiming at suppressing virus replication successfully; however, vaccination remains the most effective prevention method against this global health concern
1.
enhancing survivors of brain tumors' quality of life.
2.
Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.
3.
A protein with new anticancer activity has been identified
4.
Studies point to redlining as a 'perfect storm' for breast cancer
5.
Enzalutamide vs Abiraterone: Which is Better for mCSPC?
1.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
2.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
3.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
4.
Fc Receptor Mediated Pharmacology of Therapeutic Antibodies
5.
Progressive Strategies in Oncology and Patient Outcomes
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Managing Common Side Effects During Cancer Treatment
5.
Clinical Insights in Oncology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation